China Clinical Nutrition for Diabetes Care Market Report 2023 to 2030

China Clinical Nutrition for Diabetes Care Market Analysis

$ 3999

The China Clinical Nutrition for Diabetes Care Market was valued at $172.83 Mn in 2023 and is predicted to grow at a CAGR of 6.28% from 2023 to 2030, to $264.72 Mn by 2030. The key drivers of this industry include increasing the prevalence of diabetes, advancements in nutritional science, and initiatives for diabetes management. The key players in the industry are Nutreco, Sanofi SA, Danone Nutricia, and Abbott Nutrition among others.

ID: IN10CNPH566 CATEGORY: Pharmaceuticals GEOGRAPHY: China AUTHOR: Avantika Gupta

Buy Now

China Clinical Nutrition for Diabetes Care Market Executive Summary

The China Clinical Nutrition for Diabetes Care Market is at around $172.83 Mn in 2023 and is projected to reach $ 264.72 Mn in 2030, exhibiting a CAGR of 6.28% during the forecast period.

Clinical nutrition for diabetes care refers to specialized dietary interventions and nutritional strategies designed to manage and improve the health outcomes of people with diabetes mellitus. It involves using evidence-based nutrition treatment to help diabetic patients maintain blood sugar control, avoid complications, and enhance their overall metabolic health. The primary aim is to optimize nutrition, regulate blood sugar levels, prevent complications, and enhance overall health outcomes for those with diabetes.

The increase in the prevalence of diabetes due to aging, obesity, and unhealthy lifestyles is one of the factors contributing to the growth of the global clinical nutrition market. Obesity is a major factor leading to diabetes. Clinical nutrition including medical foods and parenteral nutrition can help relieve symptoms or slow down the progression of a chronic condition. As the number of people with diabetes continues to grow, so does the demand for these specialized food products. Patients afflicted with diabetes are at higher risk of comorbidities, as diabetes is a major cause of blindness, kidney failure, heart attacks, stroke, and lower limb amputation, as reported by the WHO.

The leading pharmaceutical companies include Baxter International Inc., Danone Nutricia is known for its extensive portfolio of medications, including those essential for diabetes care. Johnson & Johnson, Nutreco, and Roche Diabetes Care are also significant contributors to the Clinical Nutrition for Diabetes Care landscape, with continuous research and development activities.

China Clinical Nutrition for Diabetes Care Market Report 2023 to 2030

Market Dynamics

Market Growth Drivers

Increasing Prevalence of Diabetes: China has a high prevalence of diabetes, with over 140 Mn people living with the condition as of 2021. The number of adults with diabetes in China is expected to reach 164 Mn by 2030. This growing diabetes burden is a major driver for the clinical nutrition market, as proper nutrition is crucial for managing blood sugar levels and preventing complications. Recognition of the importance of nutrition therapy in treating diabetes is growing, as is the understanding of how clinical nutrition services and products can enhance patient results.

Increasing Healthcare Expenditure: China has been steadily increasing its healthcare spending in recent years. According to the World Bank, current health expenditure per capita in China grew from $583.43 in 2020 to $670.51 in 2021 The government has made efforts to expand health insurance coverage and improve access to healthcare services. This rising healthcare expenditure, combined with growing awareness about the importance of nutrition in diabetes management, is expected to boost the demand for clinical nutrition products and services in China.

Government Initiatives: The Chinese government has implemented initiatives aimed at promoting healthy lifestyles and improving diabetes management, such as the National Nutritional Plan from 2017 to 2030. This plan emphasizes healthy eating habits and balanced nutrition for disease prevention and management, including diabetes. This raises public awareness about the importance of proper nutrition for diabetes control. Government policies encouraging research and development in the food and nutrition sector can lead to the creation of innovative clinical nutrition products tailored to the specific needs of diabetic patients in China.

Market Restraints

High Product Price: Specialized clinical nutrition products can be expensive, putting them out of reach for many Chinese citizens, particularly those with limited healthcare coverage or living in low-income areas. This limits market access and hinders widespread adoption.

Lack of Access to Registered Dietitians: Limited access to high-quality clinical nutrition services and products is a significant issue in rural and underserved regions of China. The country is experiencing a shortage of healthcare professionals with expertise in clinical nutrition for managing diabetes. It is imperative to enhance the availability of certified diabetes educators and dietitians capable of offering tailored dietary guidance and assistance to individuals living with diabetes.

Regulatory Challenges

The development, production, and promotion of specialized products in the clinical nutrition market are tightly regulated. Navigating the complex regulatory environment, obtaining necessary approvals, and ensuring adherence to evolving guidelines can present obstacles for manufacturers, potentially impeding market growth.

Regulatory Landscape and Reimbursement Scenario

The National Health Commission (NHC) sets overall health policies and establishes general guidelines for food and nutrition products. National Medical Products Administration (NMPA) is responsible for the approval, registration, and regulation of medical devices and special food products, which may include some clinical nutrition products for diabetes care. Specialized foods and supplements for diabetes care, such as low-glycemic index foods and oral nutrition supplements, must be registered and approved by the CFDA before they can be marketed in China. The registration process involves evaluating the safety, quality, and efficacy of these products.

China's national health insurance schemes, such as the Urban Employee Basic Medical Insurance (UEBMI) and the Urban and Rural Resident Basic Medical Insurance (URRBMI), provide coverage for certain clinical nutrition services and products for diabetes care. Many insurance plans have caps on annual or lifetime reimbursements, which can affect long-term diabetes management. There are varying reimbursement rates across different regions and insurance plans.

Competitive Landscape

Key Players

Here are some of the major key players in the China Clinical Nutrition for Diabetes Care Market:

Abbott Nutrition
Baxter International Inc
Danone Nutricia
Pharmavite (Shanghai) Nutrition Technology Co., Ltd.
Roche Diabetes Care
Sanofi SA
Nutreco
Johnson & Johnson
Eli Lilly
Novo Nordisk

1. Executive Summary
1.1 Disease Overview
1.2 Global Scenario
1.3 Country Overview
1.4 Healthcare Scenario in Country
1.5 Patient Journey
1.6 Health Insurance Coverage in Country
1.7 Active Pharmaceutical Ingredient (API)
1.8 Recent Developments in the Country

2. Market Size and Forecasting
2.1 Epidemiology of Disease
2.2 Market Size (With Excel & Methodology)
2.3 Market Segmentation (Check all Segments in Segmentation Section)

3. Market Dynamics
3.1 Market Drivers
3.2 Market Restraints

4. Competitive Landscape
4.1 Major Market Share

4.2 Key Company Profile (Check all Companies in the Summary Section)

4.2.1 Company
4.2.1.1 Overview
4.2.1.2 Product Applications and Services
4.2.1.3 Recent Developments
4.2.1.4 Partnerships Ecosystem
4.2.1.5 Financials (Based on Availability)

5. Reimbursement Scenario
5.1 Reimbursement Regulation
5.2 Reimbursement Process for Diagnosis
5.3 Reimbursement Process for Treatment

6. Methodology and Scope

China Clinical Nutrition for Diabetes Care Market Segmentation

By Product

Oral Nutrition
Parenteral Nutrition
Enteral Feedback Formulas

By Stage

Adult
Paediatric

By Distribution Channel

Online
Retail
Institutional Sales

Methodology for Database Creation

Our database offers a comprehensive list of healthcare centers, meticulously curated to provide detailed information on a wide range of specialties and services. It includes top-tier hospitals, clinics, and diagnostic facilities across 30 countries and 24 specialties, ensuring users can find the healthcare services they need.

Additionally, we provide a comprehensive list of Key Opinion Leaders (KOLs) based on your requirements. Our curated list captures various crucial aspects of the KOLs, offering more than just general information. Whether you're looking to boost brand awareness, drive engagement, or launch a new product, our extensive list of KOLs ensures you have the right experts by your side. Covering 30 countries and 36 specialties, our database guarantees access to the best KOLs in the healthcare industry, supporting strategic decisions and enhancing your initiatives.

How Do We Get It?

Our database is created and maintained through a combination of secondary and primary research methodologies.

1. Secondary Research

With many years of experience in the healthcare field, we have our own rich proprietary data from various past projects. This historical data serves as the foundation for our database. Our continuous process of gathering data involves:

Analyzing historical proprietary data collected from multiple projects.
Regularly updating our existing data sets with new findings and trends.
Ensuring data consistency and accuracy through rigorous validation processes.

With extensive experience in the field, we have developed a proprietary GenAI-based technology that is uniquely tailored to our organization. This advanced technology enables us to scan a wide array of relevant information sources across the internet. Our data-gathering process includes:

Searching through academic conferences, published research, citations, and social media platforms
Collecting and compiling diverse data to build a comprehensive and detailed database
Continuously updating our database with new information to ensure its relevance and accuracy

2. Primary Research

To complement and validate our secondary data, we engage in primary research through local tie-ups and partnerships. This process involves:

Collaborating with local healthcare providers, hospitals, and clinics to gather real-time data.
Conducting surveys, interviews, and field studies to collect fresh data directly from the source.
Continuously refreshing our database to ensure that the information remains current and reliable.
Validating secondary data through cross-referencing with primary data to ensure accuracy and relevance.

Combining Secondary and Primary Research

By integrating both secondary and primary research methodologies, we ensure that our database is comprehensive, accurate, and up-to-date. The combined process involves:

Merging historical data from secondary research with real-time data from primary research.
Conducting thorough data validation and cleansing to remove inconsistencies and errors.
Organizing data into a structured format that is easily accessible and usable for various applications.
Continuously monitoring and updating the database to reflect the latest developments and trends in the healthcare field.

Through this meticulous process, we create a final database tailored to each region and domain within the healthcare industry. This approach ensures that our clients receive reliable and relevant data, empowering them to make informed decisions and drive innovation in their respective fields.